US 11096910
Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease
granted A61KA61K31/17A61K31/18
Quick answer
US patent 11096910 (Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease) held by The Board of Regents of the University of Texas System expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/17, A61K31/18, A61K31/202, A61K31/4196